Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.35M Hold
5,916
0.82% 24
2025
Q3
$1.37M Hold
5,916
0.83% 24
2025
Q2
$1.1M Hold
5,916
0.68% 29
2025
Q1
$1.24M Buy
+5,916
New +$1.15M 0.82% 25

Other funds holding ABBV

Pandora Wealth's ABBV Position: Q4 2025 in Review

Pandora Wealth held its AbbVie (ABBV) position steady in Q4 2025 at 5,916 shares worth $1.35M. The position accounts for 0.82% of the portfolio, ranked #24.

Pandora Wealth first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.37M in Q3 2025. 4,146 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Pandora Wealth held 5,916 shares of AbbVie worth $1.35M as of Q4 2025.
  • Pandora Wealth left its AbbVie share count unchanged in Q4 2025.
  • AbbVie made up 0.82% of Pandora Wealth's portfolio in Q4 2025, its #24 holding.
  • Pandora Wealth first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
  • Pandora Wealth's AbbVie position peaked at $1.37M in Q3 2025.
  • 4,146 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Pandora Wealth's 13F filing for Q4 2025, filed 4 Feb 2026.